Table 2.
Comparison of the effects of OA and MA administered in STZ-diabetic rats twice every third day for 5 weeks on terminal blood glucose concentrations, plasma insulin and ghrelin concentrations with untreated STZ-diabetic rats. Values are presented as means, and vertical bars indicate SEM of means (n = 6 in each group)._
| Terminal blood glucose (mmol/L) | Plasma insulin (pmol/L) | Plasma ghrelin (pmol/L) | |
|---|---|---|---|
| Non-diabetic | 5.46 ± 0.83 | 9.37 ± 0.86 | 1.99 ± 0.07 |
| STZ-diabetic | 26.95 ± 2.00♦ | 2.30 ± 0.74♦ | 3.42 ± 0.17♦ |
| STZ-OA treated | 7.54 ± 1.10* | 2.35 ± 0.84♦ | 1.96 ± 0.11* |
| STZ-MA treated | 8.35 ± 2.00* | 2.36 ± 0.79♦ | 2.44 ± 0.10* |
| STZ-Metformin treated | 7.68 ± 1.15* | 2.34 ± 0.77♦ | 2.34 ± 0.14* |
| STZ-Insulin treated | 6.45 ± 1.27* | 2.37 ± 0.43♦ | 1.91 ± 0.15* |
♦
= p<0.05 by comparison to the non-diabetic control.
*
= p<0.05 by comparison to the STZ-induced diabetic control